• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Leadership Team

Shriver, Zachary, PhD

As President and Chief Executive Officer, Zachary Shriver oversees all aspects of Visterra and its interactions with Otsuka, including research & development, accounting & finance, legal, pharmaceutical sciences & technology, operations, business development and strategy.

Zachary joined Visterra in 2009 as Vice President of Research and has 25 years of experience in the biotechnology industry. Prior to Visterra, Zachary was one of the founding scientists at Momenta Pharmaceuticals. While at Momenta, Zachary led the development of state-of-the-art analytical techniques to enable the design of several complex (polysaccharide, polypeptide, and biologics-based) products, supporting multiple INDs and NDAs. Zachary is an inventor on over 65 issued patents and has authored over 100 publications, including original research on the structure and biology of complex polysaccharides, antibody engineering, and novel, high resolution analytical techniques.

Zachary received his BA in Chemistry, summa cum laude, from Amherst College and his PhD in Applied Biosciences from MIT, where his research focused on sequencing complex polysaccharides through the integration of analytical and bioinformatics-based techniques.

< BACK TO TEAM

< BACK TO TEAM

Zachary Shriver, PhD President and Chief Executive Officer

As President and Chief Executive Officer, Zachary Shriver oversees all aspects of Visterra and its interactions with Otsuka, including research & development, accounting & finance, legal, pharmaceutical sciences & technology, operations, business development and strategy.

Zachary joined Visterra in 2009 as Vice President of Research and has 25 years of experience in the biotechnology industry. Prior to Visterra, Zachary was one of the founding scientists at Momenta Pharmaceuticals. While at Momenta, Zachary led the development of state-of-the-art analytical techniques to enable the design of several complex (polysaccharide, polypeptide, and biologics-based) products, supporting multiple INDs and NDAs. Zachary is an inventor on over 65 issued patents and has authored over 100 publications, including original research on the structure and biology of complex polysaccharides, antibody engineering, and novel, high resolution analytical techniques.

Zachary received his BA in Chemistry, summa cum laude, from Amherst College and his PhD in Applied Biosciences from MIT, where his research focused on sequencing complex polysaccharides through the integration of analytical and bioinformatics-based techniques.

< BACK TO TEAM

© 2025 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design

We use cookies on our website to see how you interact with it. By accepting, you agree to our use of such cookies. Privacy PolicyOk